Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 129, Issue 1-2, Pages 10-17Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0165-5728(02)00143-1
Keywords
cochlea; FasL; immune privilege; inner ear; mice
Categories
Funding
- NIDCD NIH HHS [DC00129, DC00139] Funding Source: Medline
- BLRD VA [I01 BX001205] Funding Source: Medline
Ask authors/readers for more resources
There is considerable evidence that hearing and vestibular function can be influenced by immune processes. The inner ear has evolved mechanisms, such as the blood-labyrinthine barrier that limit immune responses and autoimmune processes to reduce the potential for damage to cochlear cells. Recently, expression of Fas ligand (FasL) in some non-lymphoid tissue, as in the anterior chamber of the eye, has been hypothesized to play a role in protection of sensitive organs from activated T-cells. We show that under resting conditions, cochlear cells express little or no FasL. However, after exposure to interferon-gamma in vitro. FasL is induced in many neonatal cochlear cells. In addition, we show that FasL is upregulated in adult cochlear cells after induction of a sterile labyrinthitis in vivo. The induction of FasL by inflammation may serve to limit cochlear immune responses, and to protect sensorineural tissue from immune and autoimmune damage. (C) 2002 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available